+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
Atrial Fibrillation- Pipeline Insight, 2025 - Product Thumbnail Image

Atrial Fibrillation- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Antibody Drug Conjugates Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 210 Pages
  • Global
From
Ataxia Market Report 2025 - Product Thumbnail Image

Ataxia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Headache Disorders Market Report 2025 - Product Thumbnail Image

Headache Disorders Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neurofibromatosis Treatment Market Report 2025 - Product Thumbnail Image

Neurofibromatosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Neuralgia Treatment Market Report 2025 - Product Thumbnail Image

Neuralgia Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Cell Therapy Technologies Market Report 2025 - Product Thumbnail Image

Cell Therapy Technologies Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Precision Medicine Market Report 2025 - Product Thumbnail Image

Precision Medicine Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Cell and Gene Therapy Market Report 2025 - Product Thumbnail Image

Cell and Gene Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator